Johnson & Johnson did improve performance in its medical device business last year, but CEO Alex Gorsky said the company has more work ahead to return to above-market growth in 2020.
privacy policy | terms of use | contact us | advertise | pharma jobs | pharma blogs | facebook | twitter
Copyright © 2024,